Cleared Traditional

K221073 - Sterile Hypodermic Syringes for Single ...

K221073 is an FDA 510(k) clearance for Sterile Hypodermic Syringes for Single ..., manufactured by Sichuan Prius Biotechnology Co., Ltd.. The device is a Class 2 General Hospital device with product code MEG cleared through the Traditional 510(k) pathway after a 175-day FDA review.

K221073 · Sichuan Prius Biotechnology Co., Ltd. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2022
Decision
175d
Days
Class 2
Risk

K221073 is an FDA 510(k) clearance for the Sterile Hypodermic Syringes for Single Use with Safety Needles. Classified as Syringe, Antistick (product code MEG), Class II - Special Controls.

Submitted by Sichuan Prius Biotechnology Co., Ltd. (Yibin, CN). The FDA issued a Cleared decision on October 4, 2022 after a review of 175 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5860 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Sichuan Prius Biotechnology Co., Ltd. devices

FDA 510(k) Submission Details - K221073

510(k) Number K221073 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 12, 2022
Decision Date October 04, 2022
Days to Decision 175 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
46d slower than avg
Panel avg: 129d · This submission: 175d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MEG Device Classification - Class 2, Special Controls

Product Code MEG Syringe, Antistick
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Consultant

Mid-Link Consulting Co, Ltd.
Diana Hong

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MEG Syringe, Antistick

All 41
Devices cleared under the same product code (MEG) and FDA review panel - the closest regulatory comparables to K221073.
Disposable Automatically Retractable Safety Syringes (with detachable needle)
K222452 · Shantou Wealy Medical Instrument Co.,Ltd · Nov 2022
Sterile Disposable Syringe with Safety Needle, Sterile Disposable Syringe with Needle, Sterile Disposable Safety Needle, Sterile Disposable Needle
K221247 · Jiangsu Kangbao Medical Equipment Co., Ltd. · Nov 2022
Disposable Sterile Syringe with permanently attached needle
K220057 · Shinva Ande Healthcare Apparatus Co., Ltd. · Oct 2022
Safety Insulin Syringes
K220061 · Berpu Medical Technology Co., Ltd. · Aug 2022
Jeesung Safety Syringe and Single Use Needles
K212518 · Jeesung Medical Co., Ltd. · Aug 2022
Automatically Retractable Safety Syringe
K213077 · Zhejiang Lingyang Medical Apparatus Co., Ltd. · Apr 2022